VEGFA and neoplasm: Emergence from dormancy and tumor progression may resume after an “angiogenic switch” in which there is a shift in the balance between pro-angiogenic factors [e.g., vascular endothelial growth factor (VEGF)] and anti-angiogenic factors (e.g., thrombospondin-1) (116).